{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:58:32Z","timestamp":1740124712885,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41409-021-01492-7","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:25:42Z","timestamp":1634599542000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-8270","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Velier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Arcani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9my","family":"Magalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Benyamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Granel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Dignat George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4889","authenticated-orcid":false,"given":"Christian","family":"Chabannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"1492_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.berh.2016.02.004","volume":"29","author":"N Del Papa","year":"2015","unstructured":"Del Papa N, Zaccara E. From mechanisms of action to therapeutic application: a review on current therapeutic approaches and future directions in systemic sclerosis. Best Pr Res Clin Rheumatol. 2015;29:756\u201369.","journal-title":"Best Pr Res Clin Rheumatol"},{"key":"1492_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, et al. Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis. 2001;60:577\u201384.","journal-title":"Ann Rheum Dis"},{"key":"1492_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.autrev.2005.03.003","volume":"4","author":"P de Buys","year":"2005","unstructured":"de Buys P, Khanna D, Furst DE. Hemopoietic stem cell transplantation in rheumatic diseases-an update. Autoimmun Rev. 2005;4:442\u20139.","journal-title":"Autoimmun Rev"},{"key":"1492_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bbmt.2018.01.020","volume":"24","author":"R Shouval","year":"2018","unstructured":"Shouval R, Furie N, Raanani P, Nagler A, Gafter-Gvili A. Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis. Biol Blood Marrow Transpl. 2018;24:937\u201344.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1492_CR5","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3389\/fimmu.2018.02390","volume":"9","author":"N Del Papa","year":"2018","unstructured":"Del Papa N, Pignataro F, Zaccara E, Maglione W, Minniti A. Autologous hematopoietic stem cell transplantation for treatment of systemic sclerosis. Front Immunol. 2018;9:2390.","journal-title":"Front Immunol"},{"key":"1492_CR6","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","volume":"104","author":"G Pugnet","year":"2017","unstructured":"Pugnet G, Castilla-Llorente C, Puyade M, Terriou L, Badoglio M, Deligny C, et al. Indications et suivi des autogreffes de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans les maladies auto-immunes et auto-inflammatoires: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC). Bull Cancer. 2017;104:S169\u2013S180.","journal-title":"Bull Cancer"},{"key":"1492_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","volume":"72","author":"T Alexander","year":"2021","unstructured":"Alexander T, Greco R, Snowden JA. Hematopoietic stem cell transplantation for autoimmune disease. Annu Rev Med. 2021;72:215\u201328.","journal-title":"Annu Rev Med"},{"key":"1492_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327\u201339.","journal-title":"Ann Rheum Dis"},{"key":"1492_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41409-019-0516-2","volume":"54","author":"RF Duarte","year":"2019","unstructured":"Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, et al. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transpl. 2019;54:1525\u201352.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","volume":"113","author":"T Alexander","year":"2009","unstructured":"Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2009;113:214\u201323.","journal-title":"Blood"},{"key":"1492_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/art.21036","volume":"52","author":"D Farge","year":"2005","unstructured":"Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. 2005;52:1555\u201363.","journal-title":"Arthritis Rheum"},{"key":"1492_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transpl. 2012;47:770\u201390.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","volume":"127","author":"EM Delemarre","year":"2016","unstructured":"Delemarre EM, van den Broek T, Mijnheer G, Meerding J, Wehrens EJ, Olek S, et al. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells. Blood. 2016;127:91\u2013101.","journal-title":"Blood"},{"key":"1492_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet Lond Engl. 2011;378:498\u2013506.","journal-title":"Lancet Lond Engl"},{"key":"1492_CR15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA. 2014;311:2490\u20138.","journal-title":"JAMA"},{"key":"1492_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, et al. Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med. 2018;378:35\u201347.","journal-title":"N Engl J Med"},{"key":"1492_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3324\/haematol.2019.230128","volume":"106","author":"J Henes","year":"2020","unstructured":"Henes J, Oliveira MC, Labopin M, Badoglio M, Scherer HU, Del Papa N, et al. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Haematologica. 2020;106:375\u201383.","journal-title":"Haematologica"},{"key":"1492_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2017.56","volume":"52","author":"D Farge","year":"2017","unstructured":"Farge D, Burt RK, Oliveira MC, Mousseaux E, Rovira M, Marjanovic Z, et al. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. Bone Marrow Transpl. 2017;52:1495\u2013503.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR19","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","volume":"1","author":"JA Snowden","year":"2017","unstructured":"Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, et al. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Adv. 2017;1:2742\u201355.","journal-title":"Blood Adv"},{"key":"1492_CR20","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/art.21908","volume":"54","author":"RA Nash","year":"2006","unstructured":"Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA, et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis. Arthritis Rheum. 2006;54:1982\u20136.","journal-title":"Arthritis Rheum"},{"key":"1492_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bmt.1705611","volume":"39","author":"Y Loh","year":"2007","unstructured":"Loh Y, Oyama Y, Statkute L, Verda L, Quigley K, Yaung K, et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease? Bone Marrow Transpl. 2007;39:435\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bmt.2015.299","volume":"51","author":"MC Oliveira","year":"2016","unstructured":"Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transpl. 2016;51:501\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR23","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 2002;46:2301\u20139.","journal-title":"Arthritis Rheum"},{"key":"1492_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/bmt.2014.251","volume":"50","author":"T Alexander","year":"2015","unstructured":"Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, et al. SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transpl. 2015;50:173\u201380.","journal-title":"Bone Marrow Transpl"},{"key":"1492_CR25","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267\u201374.","journal-title":"Exp Hematol"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"1492_CR27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292\u20138.","journal-title":"Circulation"},{"key":"1492_CR28","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25:2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1492_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13287-016-0317-0","volume":"7","author":"SC Abreu","year":"2016","unstructured":"Abreu SC, Weiss DJ, Rocco PRM. Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases? Stem Cell Res Ther. 2016;7:53.","journal-title":"Stem Cell Res Ther"},{"key":"1492_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383\u201396.","journal-title":"Nat Rev Immunol"},{"key":"1492_CR31","doi-asserted-by":"publisher","unstructured":"Rozier P, Maria A, Goulabchand R, Jorgensen C, Guilpain P, No\u00ebl D. Mesenchymal stem cells in systemic sclerosis: allogenic or autologous approaches for therapeutic use? Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.02938.","DOI":"10.3389\/fimmu.2018.02938"},{"key":"1492_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-153-10-201011160-00007","volume":"153","author":"S Guiducci","year":"2010","unstructured":"Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M, et al. Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med. 2010;153:650\u20134.","journal-title":"Ann Intern Med"},{"key":"1492_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.leu.2404996","volume":"22","author":"M Christopeit","year":"2008","unstructured":"Christopeit M, Schendel M, F\u00f6ll J, M\u00fcller LP, Keysser G, Behre G. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia. 2008;22:1062\u20134.","journal-title":"Leukemia"},{"key":"1492_CR34","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/art.30431","volume":"63","author":"G Keyszer","year":"2011","unstructured":"Keyszer G, Christopeit M, Fick S, Schendel M, Taute BM, Behre G, et al. Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum. 2011;63:2540\u20132.","journal-title":"Arthritis Rheum"},{"key":"1492_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13287-018-1053-4","volume":"9","author":"J Liang","year":"2018","unstructured":"Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, et al. Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study. Stem Cell Res Ther. 2018;9:312.","journal-title":"Stem Cell Res Ther"},{"key":"1492_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13075-017-1373-2","volume":"19","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liang J, Tang X, Wang D, Feng X, Wang F, et al. Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. Arthritis Res Ther. 2017;19:165.","journal-title":"Arthritis Res Ther"},{"key":"1492_CR37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/kel436","volume":"46","author":"Y Kamata","year":"2007","unstructured":"Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, et al. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology. 2007;46:882\u20134.","journal-title":"Rheumatology"},{"key":"1492_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/ken407","volume":"48","author":"T Nevskaya","year":"2008","unstructured":"Nevskaya T, Ananieva L, Bykovskaia S, Eremin I, Karandashov E, Khrennikov J, et al. Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis. Rheumatology. 2008;48:61\u201364.","journal-title":"Rheumatology"},{"key":"1492_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/rheumatology\/ket432","volume":"53","author":"G Takagi","year":"2014","unstructured":"Takagi G, Miyamoto M, Tara S, Kirinoki-Ichikawa S, Kubota Y, Hada T, et al. Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study. Rheumatology. 2014;53:854\u20139.","journal-title":"Rheumatology"},{"key":"1492_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/s10165-010-0274-x","volume":"20","author":"Y Ishigatsubo","year":"2010","unstructured":"Ishigatsubo Y, Ihata A, Kobayashi H, Hama M, Kirino Y, Ueda A, et al. Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells. Mod Rheumatol. 2010;20:263\u201372.","journal-title":"Mod Rheumatol"},{"key":"1492_CR41","doi-asserted-by":"publisher","first-page":"e020479","DOI":"10.1136\/bmjopen-2017-020479","volume":"8","author":"FCC van Rhijn-Brouwer","year":"2018","unstructured":"van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Schuurman AH, Bonte-Mineur F, Vonk MC, et al. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol. BMJ Open. 2018;8:e020479.","journal-title":"BMJ Open"},{"key":"1492_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211\u201328.","journal-title":"Tissue Eng"},{"key":"1492_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/PRS.0000000000000104","volume":"133","author":"J Bank","year":"2014","unstructured":"Bank J, Fuller SM, Henry GI, Zachary LS. Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality. Plast Reconstr Surg. 2014;133:1109\u201318.","journal-title":"Plast Reconstr Surg"},{"key":"1492_CR44","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3727\/096368914X685636","volume":"24","author":"N Del Papa","year":"2015","unstructured":"Del Papa N, Di Luca G, Sambataro D, Zaccara E, Maglione W, Gabrielli A, et al. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis. Cell Transpl. 2015;24:2297\u2013305.","journal-title":"Cell Transpl"},{"key":"1492_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","volume":"21","author":"N Del Papa","year":"2019","unstructured":"Del Papa N, Di Luca G, Andracco R, Zaccara E, Maglione W, Pignataro F, et al. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study. Arthritis Res Ther. 2019;21:7.","journal-title":"Arthritis Res Ther"},{"key":"1492_CR46","doi-asserted-by":"publisher","unstructured":"Pignatti M, Spinella A, Cocchiara E, Boscaini G, Lusetti IL, Citriniti G et al. Autologous fat grafting for the oral and digital complications of systemic sclerosis: results of a prospective study. Aesthetic Plast Surg. 2020. https:\/\/doi.org\/10.1007\/s00266-020-01848-2.","DOI":"10.1007\/s00266-020-01848-2"},{"key":"1492_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.isjp.2020.07.002","volume":"23","author":"FHK Jeon","year":"2020","unstructured":"Jeon FHK, Griffin M, Denton CP, Butler PEM. Feasibility study of stem-cell enriched autologous lipotransfer to treat oro-facial fibrosis in systemic sclerosis (Sys-Stem): Protocol for open-label randomised controlled trial. Int J Surg Protoc. 2020;23:6\u201310.","journal-title":"Int J Surg Protoc"},{"key":"1492_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/096368914X674062","volume":"24","author":"N Del Papa","year":"2015","unstructured":"Del Papa N, Caviggioli F, Sambataro D, Zaccara E, Vinci V, Di Luca G, et al. Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis. Cell Transpl. 2015;24:63\u201372.","journal-title":"Cell Transpl"},{"key":"1492_CR49","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1097\/GOX.0000000000000621","volume":"4","author":"N Sautereau","year":"2016","unstructured":"Sautereau N, Daumas A, Truillet R, Jouve E, Magalon J, Veran J, et al. Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients. Plast Reconstr Surg Glob Open. 2016;4:e660.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"1492_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6568016","volume":"2018","author":"M Gheisari","year":"2018","unstructured":"Gheisari M, Ahmadzadeh A, Nobari N, Iranmanesh B, Mozafari N. Autologous fat grafting in the treatment of facial scleroderma. Dermatol Res Pr. 2018;2018:1\u20137.","journal-title":"Dermatol Res Pr"},{"key":"1492_CR51","doi-asserted-by":"publisher","first-page":"e0218068","DOI":"10.1371\/journal.pone.0218068","volume":"14","author":"A Almadori","year":"2019","unstructured":"Almadori A, Griffin M, Ryan CM, Hunt DF, Hansen E, Kumar R, et al. Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. PloS One. 2019;14:e0218068.","journal-title":"PloS One"},{"key":"1492_CR52","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/ATVBAHA.119.312425","volume":"39","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen S, Zhang X, Pei M. Significance of cellular cross-talk in stromal vascular fraction of adipose tissue in neovascularization. Arterioscler Thromb Vasc Biol. 2019;39:1034\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1492_CR53","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","volume":"74","author":"B Granel","year":"2015","unstructured":"Granel B, Daumas A, Jouve E, Harl\u00e9 J-R, Nguyen P-S, Chabannon C, et al. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015;74:2175\u201382.","journal-title":"Ann Rheum Dis"},{"key":"1492_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.retram.2016.10.006","volume":"65","author":"A Daumas","year":"2017","unstructured":"Daumas A, Magalon J, Jouve E, Truillet R, Casanova D, Giraudo L, et al. Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients. Curr Res Transl Med. 2017;65:40\u20133.","journal-title":"Curr Res Transl Med"},{"key":"1492_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3727\/096368912X639017","volume":"22","author":"N Scuderi","year":"2013","unstructured":"Scuderi N, Ceccarelli S, Onesti MG, Fioramonti P, Guidi C, Romano F, et al. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transpl. 2013;22:779\u201395.","journal-title":"Cell Transpl"},{"key":"1492_CR56","doi-asserted-by":"publisher","first-page":"2416192","DOI":"10.1155\/2016\/2416192","volume":"2016","author":"MG Onesti","year":"2016","unstructured":"Onesti MG, Fioramonti P, Carella S, Fino P, Marchese C, Scuderi N. Improvement of mouth functional disability in systemic sclerosis patients over one year in a trial of fat transplantation versus adipose-derived stromal cells. Stem Cells Int. 2016;2016:2416192.","journal-title":"Stem Cells Int"},{"key":"1492_CR57","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/PRS.0b013e31829fe1b0","volume":"132","author":"P Tonnard","year":"2013","unstructured":"Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017\u201326.","journal-title":"Plast Reconstr Surg"},{"key":"1492_CR58","doi-asserted-by":"publisher","unstructured":"Passweg JR, Baldomero H, Chabannon C, Basak GW, de la C\u00e1mara R et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021. https:\/\/doi.org\/10.1038\/s41409-021-01227-8.","DOI":"10.1038\/s41409-021-01227-8"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01492-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01492-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T16:07:03Z","timestamp":1675786023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01492-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01492-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}